Home › Compare › CLPIF vs ABBV
CLPIF yields 4.80% · ABBV yields 3.06%● Live data
📍 CLPIF pulled ahead of the other in Year 1
Combined, CLPIF + ABBV cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of CLPIF + ABBV for your $10,000?
Compagnie des Alpes SA, together with its subsidiaries, operates leisure facilities. It operates through Ski Areas, Leisure Parks, and Holdings and Supports segments. The Ski Areas segment operates ski lifts; and equips, maintains, and operates ski areas, as well as maintains ski runs and trails. It also sells land to real-estate developers. This segment operates ski resorts under the La Plagne, Les Arcs, Peisey-Vallandry, Tignes, Val d'Isère, Les Menuires, Méribel, Flaine, Serre Chevalier, Les Deux Alpes, Samoëns, and Megeve. The Leisure Parks segment develops and operates theme parks, combined amusement and animal parks, water parks, wax museums, and tourist sites. This segment operates leisure parks under Parc Astérix, Futuroscope, Grévin Paris, France Miniature, Walibi Rhône-Alpes, Walibi Holland, Walibi Belgium, Aqualibi, Bellewaerde, Aquapark, and Familypark. The Holdings and Supports segment is involved in the provision of consulting services; and tour-operator, travel agency, and real estate businesses. Compagnie des Alpes SA was founded in 1989 and is headquartered in Paris, France.
Full CLPIF Calculator →AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Full ABBV Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.